In a joint funding initiative, NHMRC and Cancer Australia are investing $15 million into high quality health and medical research to enhance ...
Dermatomyositis and Malignancy Risk: The Predictive Value of Autoantibodies and Patient Risk Factors
Although autoantibody profiling has enhanced risk stratification and informed cancer screening strategies in DM, substantial therapeutic challenges remain.
Analysis of Alzheimer’s brains revealed age-related accumulation of cancer driver mutations, particularly in microglia. These ...
Scientists have uncovered a surprising overlap between cancer genetics and Alzheimer’s disease, involving mutations in the ...
These discoveries suggest that certain cancer treatments may be useful therapeutically for Alzheimer’s disease.
A round-up of some of the latest advances in cancer reseacher presented by MSK scientists at the 2026 American Association ...
As the body ages, cells naturally accumulate dozens of genetic mutations each year. New research from Boston Children's ...
While receiving a metastatic cancer diagnosis can be overwhelming, it is important to keep in mind that not all cancers are ...
A research team at the University of Cologne's Center for Molecular Medicine Cologne (CMMC) has discovered that the protein ...
Researchers are rethinking how we target bowel cancer growth pathways, using patient-derived organoids to identify whether hyperactivating growth genes, rather than inhibiting them, improves outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results